|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
65,769,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Nuvalent is a biopharmaceutical company. Co.'s product candidate, NVL-520, is a ROS proto-oncogene 1 (ROS1)-selective inhibitor designed with the aim to address the clinical challenges of emergent treatment resistance, central nervous system (CNS)-related adverse events, and brain metastases that may limit the use of available ROS1 tyrosine kinase inhibitors. Co.'s another product candidate, NVL-655, is a brain-penetrant anaplastic lymphoma kinase (ALK)-selective inhibitor, designed with the aim to address the clinical challenges of emergent treatment resistance, CNS-related adverse events, and brain metastases that may limit the use of first-, second-, and third-generation ALK inhibitors.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
799,253 |
| Total Buy Value |
$0 |
$0 |
$0 |
$26,774,976 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
1,250,333 |
1,491,679 |
1,695,539 |
1,980,239 |
| Total Sell Value |
$90,153,514 |
$108,253,123 |
$118,381,079 |
$126,341,662 |
| Total People Sold |
5 |
7 |
8 |
8 |
| Total Sell Transactions |
17 |
26 |
47 |
83 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Miller Deborah Ann |
Chief Legal Officer |
• – – |
2023-12-19 |
4 |
S |
$75.00 |
$375,000 |
D/D |
(5,000) |
0 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2023-12-19 |
4 |
OE |
$18.93 |
$94,650 |
D/D |
5,000 |
5,000 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2023-12-18 |
4 |
S |
$75.82 |
$2,505,548 |
D/D |
(33,046) |
0 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2023-12-18 |
4 |
OE |
$27.85 |
$920,331 |
D/D |
33,046 |
33,046 |
|
- |
|
| Protopapas Anna |
Director |
– • – |
2023-12-18 |
4 |
S |
$75.67 |
$378,350 |
D/D |
(5,000) |
0 |
|
- |
|
| Protopapas Anna |
Director |
– • – |
2023-12-18 |
4 |
OE |
$9.36 |
$46,800 |
D/D |
5,000 |
5,000 |
|
- |
|
| Noci Darlene |
Chief Development Officer |
• – – |
2023-12-18 |
4 |
S |
$75.82 |
$3,032,800 |
D/D |
(40,000) |
0 |
|
- |
|
| Noci Darlene |
Chief Development Officer |
• – – |
2023-12-18 |
4 |
OE |
$1.08 |
$188,139 |
D/D |
40,000 |
40,000 |
|
- |
|
| Balcom Alexandra |
Chief Financial Officer |
• – – |
2023-12-18 |
4 |
S |
$75.82 |
$2,274,600 |
D/D |
(30,000) |
0 |
|
- |
|
| Balcom Alexandra |
Chief Financial Officer |
• – – |
2023-12-18 |
4 |
OE |
$1.08 |
$32,400 |
D/D |
30,000 |
30,000 |
|
- |
|
| Shair Matthew |
Director |
– • – |
2023-11-28 |
4 |
AS |
$61.68 |
$566,303 |
D/D |
(9,150) |
1,843,848 |
|
- |
|
| Shair Matthew |
Director |
– • – |
2023-10-24 |
4 |
AS |
$50.63 |
$4,648,872 |
D/D |
(91,700) |
1,852,998 |
|
- |
|
| Noci Darlene |
Chief Development Officer |
• – – |
2023-10-04 |
4 |
AS |
$55.41 |
$1,119,702 |
D/D |
(20,000) |
0 |
|
- |
|
| Noci Darlene |
Chief Development Officer |
• – – |
2023-10-04 |
4 |
OE |
$1.08 |
$111,150 |
D/D |
20,000 |
20,000 |
|
- |
|
| Turner Christopher Durant |
Chief Medical Officer |
• – – |
2023-10-04 |
4 |
AS |
$51.32 |
$432,031 |
D/D |
(7,995) |
14,513 |
|
- |
|
| Turner Christopher Durant |
Chief Medical Officer |
• – – |
2023-10-04 |
4 |
OE |
$6.89 |
$55,086 |
D/D |
7,995 |
22,508 |
|
- |
|
| Noci Darlene |
Chief Development Officer |
• – – |
2023-10-02 |
4 |
AS |
$45.35 |
$137,649 |
D/D |
(3,000) |
0 |
|
- |
|
| Noci Darlene |
Chief Development Officer |
• – – |
2023-10-02 |
4 |
OE |
$1.08 |
$3,240 |
D/D |
3,000 |
3,000 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2023-09-15 |
4 |
AS |
$47.43 |
$95,283 |
D/D |
(2,000) |
0 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2023-09-15 |
4 |
OE |
$6.89 |
$13,780 |
D/D |
2,000 |
2,000 |
|
- |
|
| Noci Darlene |
Chief Development Officer |
• – – |
2023-09-01 |
4 |
AS |
$46.12 |
$139,692 |
D/D |
(3,000) |
0 |
|
- |
|
| Noci Darlene |
Chief Development Officer |
• – – |
2023-09-01 |
4 |
OE |
$1.08 |
$3,240 |
D/D |
3,000 |
3,000 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2023-08-15 |
4 |
AS |
$42.46 |
$85,310 |
D/D |
(2,000) |
0 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2023-08-15 |
4 |
OE |
$6.89 |
$13,780 |
D/D |
2,000 |
2,000 |
|
- |
|
| Noci Darlene |
Chief Development Officer |
• – – |
2023-08-01 |
4 |
AS |
$49.69 |
$149,844 |
D/D |
(3,000) |
0 |
|
- |
|
150 Records found
|
|
Page 2 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
